Crispr/cas genome editing

InterventionPreclinical

1 paper1 finding

Outcomes

1

SNCA

downin reviews1

1 study

Crispr/cas genome editing decreases SNCA.
“reduction of alpha-synuclein expression in PD”
Reviewin PD
CRISPR/cas genome editing for neurodegenerative diseases: Mechanisms, therapeutic advances, and clinical prospects
Ageing research reviews17 Oct 2025

Latest

Ageing Research Reviews19 Oct

CRISPR/cas genome editing for neurodegenerative diseases: Mechanisms, therapeutic advances, and clinical prospects

ReviewNeurodegenerative disease